Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tjeffe01
    Junior Member
    • Aug 2013
    • 4

    #1

    Hello

    Hello,

    My name is Taylor. I work at the University of Guelph, in Ontario Canada. I work on glyphosate resistant giant ragweed. We just sent out four samples for RNAseq analysis to look at differences in gene expression between sprayed and unsprayed susceptible and resistant plants.

    Our biggest problem is that we have little to no genetic data available on our species; no reference genome (and only about 40 entries in NCBI).

    Glad to be a part of the community,
    Taylor
  • piyo2
    Junior Member
    • Oct 2010
    • 4

    #2
    If this genome is important, why not go for a de novo assembly to actually have a reference genome? This way you'll have genomic data with RNA-Seq (plus a very nice project and probably a thesis to go with it). I am guessing that ragweed is somewhere between 100-200 Mbp in size. The best de novo assembly strategy is lots of throughput and coverage with Illumina short reads, plus some long PacBio reads to span repeats and join contigs. My best guess is that this will cost $10K (all in at service lab) This doesn't seem out of reach for an important contribution to the field.

    Mike Schatz at CSHL has done a lot of work in this area: http://schatzlab.cshl.edu/presentati...%20Genomes.pdf

    Genome Quebec can provide service and has informatics experience on hybrid de novo assemblies. http://gqinnovationcenter.com/servic...acBio.aspx?l=e

    **Disclaimer: I work for a sequencing company.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-13-2026, 12:22 PM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    50 views
    0 reactions
    Last Post SEQadmin2  
    Working...